Skip to main content
Top
Published in: International Urology and Nephrology 4/2013

01-08-2013 | Nephrology – Case Report

Pregnancy in women with Alport syndrome

Authors: Francesca Crovetto, Gabriella Moroni, Barbara Zaina, Barbara Acaia, Manuela W. Ossola, Luigi Fedele

Published in: International Urology and Nephrology | Issue 4/2013

Login to get access

Abstract

Background

Little is known about pregnancy in women with Alport syndrome (AS), as only four cases have been reported in the literature. We herein describe the course of pregnancy in two sisters with overt forms of AS.

Cases

Both women were diagnosed as having autosomal recessive AS. Before pregnancy, their renal function and their blood pressure were normal, and proteinuria values were below 2 g/24 h. Both patients faced a progressive and remarkable increase in proteinuria during pregnancy, with subsequent hypoproteinemia. The clinical condition worsened, particularly in the first case, who was managed with some success with a combination of diuretics. She delivered at 32 weeks of pregnancy. The second patient was less challenging and she delivered at 36 weeks. Proteinuria returned to pre-pregnancy levels in both cases, after delivery.

Conclusion

Management of pregnant women with overt AS is challenging and worsening of renal disease has to be expected. The use of diuretic therapy may be of benefit.
Literature
1.
go back to reference North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) (2008) North American Pediatric Renal Transplant Cooperative Study annual report 2008 NAPRTCS, Boston North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) (2008) North American Pediatric Renal Transplant Cooperative Study annual report 2008 NAPRTCS, Boston
2.
go back to reference Hudson BG, Tryggvason K, Sundaramoorthy M, Neisoln EG (2003) Alport syndrome, Goodpasture’s syndrome, and type IV collagen. N Engl J Med 348:2543–2556PubMedCrossRef Hudson BG, Tryggvason K, Sundaramoorthy M, Neisoln EG (2003) Alport syndrome, Goodpasture’s syndrome, and type IV collagen. N Engl J Med 348:2543–2556PubMedCrossRef
3.
go back to reference Matsubara S, Ueda Y, Takahashi H, Nagai T, Kuwata T, Muto S, Yamaguchi T et al (2009) Pregnancy complicated with Alport syndrome: a good obstetric outcome and failure to diagnose an infant born to a mother with Alport syndrome by umbilical cord immunoflorescence staining. J Obstet Gynecol Res 35:1109–1114CrossRef Matsubara S, Ueda Y, Takahashi H, Nagai T, Kuwata T, Muto S, Yamaguchi T et al (2009) Pregnancy complicated with Alport syndrome: a good obstetric outcome and failure to diagnose an infant born to a mother with Alport syndrome by umbilical cord immunoflorescence staining. J Obstet Gynecol Res 35:1109–1114CrossRef
4.
5.
go back to reference Nakano Y, Yuhara C, Saito J, Miyazaki R, Yoshida K, Kuwabara Y (1993) Pregnancy with Alport syndrome: a case report. Nissanpu Tokyo Kaishi 42:302–304 Nakano Y, Yuhara C, Saito J, Miyazaki R, Yoshida K, Kuwabara Y (1993) Pregnancy with Alport syndrome: a case report. Nissanpu Tokyo Kaishi 42:302–304
6.
go back to reference Omori H, Wa S, Mikami S et al (2004) A case of Alport syndrome with deteriorating nephrosis during pregnancy. Nihon Jinzou Gakkaishi 46:532 Omori H, Wa S, Mikami S et al (2004) A case of Alport syndrome with deteriorating nephrosis during pregnancy. Nihon Jinzou Gakkaishi 46:532
7.
go back to reference Podymow T, August P, Akbari A (2010) Management of renal disease in pregnancy. Obstet Gynecol Clin N Am 37:195–210CrossRef Podymow T, August P, Akbari A (2010) Management of renal disease in pregnancy. Obstet Gynecol Clin N Am 37:195–210CrossRef
9.
go back to reference Rheault MN (2012) Women and Alport syndrome. Pediatr Nephrol 27(1):41–46 Rheault MN (2012) Women and Alport syndrome. Pediatr Nephrol 27(1):41–46
Metadata
Title
Pregnancy in women with Alport syndrome
Authors
Francesca Crovetto
Gabriella Moroni
Barbara Zaina
Barbara Acaia
Manuela W. Ossola
Luigi Fedele
Publication date
01-08-2013
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 4/2013
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-012-0154-8

Other articles of this Issue 4/2013

International Urology and Nephrology 4/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.